Effects of Post‐transplant Enteral Nutrition with an Immunomodulating Diet Containing Hydrolyzed Whey Peptide after Liver Transplantation
- 29 February 2012
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 36 (7) , 1666-1671
Abstract
Background Complications due to infections, including bacteremia, often arise after liver transplantation (LT) and are the most frequent causes of in-hospital death. Hydrolyzed whey peptide (HWP), a protein complex derived from milk, has anti-inflammatory effects. The present study retrospectively analyzes the effects of early enteral nutrition with a new immunomodulating diet (IMD) enriched with HWP in patients after living-donor LT (LDLT). Methods Data from 76 consecutive adult patients who underwent LDLT at our institute between September 2009 and March 2011 were retrospectively analyzed. The new IMD enriched with HWP and a conventional elemental diet were administered enterally to 40 (HWP group) and 36 (control group) patients, respectively, within the first 24 h after surgery. Results The characteristics of patients and surgical parameters did not differ between the two groups. The incidence of bacteremia was significantly lower in the HWP (15%) than in the control group (47%) (p = 0.002). The in-hospital mortality due to infection was a little lower in the HWP group than in the control group, although there was no statistical difference (p = 0.145). The fasting blood glucose level at postoperative day 7 was significantly lower in the HWP group than in the control group (p = 0.005). The incidence of acute cellular rejection was similar between the two groups (p = 0.858). Conclusion Early enteral nutrition with the new IMD enriched with HWP can prevent post-transplant bacteremia and post-transplant hyperglycemia without increasing the incidence of acute cellular rejection.Keywords
This publication has 19 references indexed in Scilit:
- Severe Intraoperative Hyperglycemia Is Independently Associated With Surgical Site Infection After Liver TransplantationTransplantation, 2009
- Current status of liver transplantation across ABO blood-type barrierJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Present status of ABO-incompatible living donor liver transplantation in JapanHepatology, 2007
- Outcomes of Adult-to-Adult Living Donor Liver TransplantationAnnals of Surgery, 2007
- Nutrition for the liver transplant patientLiver Transplantation, 2006
- Hepatoprotective Effects of Whey Protein onD-Galactosamine-Induced Hepatitis and Liver Fibrosis in RatsBioscience, Biotechnology, and Biochemistry, 2006
- RIGHT LOBE GRAFT IN LIVING DONOR LIVER TRANSPLANTATION 1,2Transplantation, 2000
- Identification of High– and Low–Risk Patients Before Liver Transplantation: A Prospective Cohort Study of Nutritional and Metabolic Parameters in 150 PatientsHepatology, 1997
- Nutritional Issues in Hepatobiliary SurgerySeminars in Liver Disease, 1994
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988